(Q28196350)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12781905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

How cost-effective are new preventive strategies for cardiovascular disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12781905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

main subject

cardiovascular disease

1 reference

based on heuristic

inferred from title

author

Jeffrey L Probstfield

series ordinal

1

object named as

Jeffrey L Probstfield

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12781905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12781905%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12781905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12781905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

10A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12781905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

22G-27G

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12781905%20AND%20SRC:MED&resulttype=core&format=json

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

The distinction between cost and charges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

Clinical economics. A guide to the economic analysis of clinical practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

Cost-effectiveness analysis in heart disease, Part I: General principles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

Cost-effectiveness analysis in heart disease, Part II: Preventive therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

Cost-effectiveness analysis in heart disease, Part III: Ischemia, congestive heart failure, and arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

Cost effectiveness of ramipril treatment for cardiovascular risk reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

The ongoing telmisartan alone and in combination with ramipril global endpoint trial program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900229-7

10.1016/S0002-9149(03)00229-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12781905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference